Safety and Effectiveness of Etanercept Biosimilar SB4 for Rheumatic Diseases in South Korea: Real-World Post-marketing Surveillance Data

被引：0
|
作者：
Wan-Hee Yoo
Young Mo Kang
Dong Wook Kim
Eun Ha Kang
Yeon-Ah Lee
Chang-Hee Suh
Yoon-Kyoung Sung
Sang-Hoon Lee
Dong-Ha Gu
Jiwon Lee
Jung-Yoon Choe
机构：
[1] Jeonbuk National University Medical School and Research Institute of Clinical Medicine of Jeonbuk National University Hospital,Division of Rheumatology, Department of Internal Medicine
[2] Kyungpook National University Hospital,Division of Rheumatology, Department of Internal Medicine
[3] Inje University Busan Paik Hospital,Division of Rheumatology Department of Internal Medicine
[4] Seoul National University Bundang Hospital,Division of Rheumatology, Department of Internal Medicine
[5] Kyung Hee University Hospital,Department of Rheumatology
[6] Ajou University School of Medicine,Department of Rheumatology
[7] Hanyang University Hospital for Rheumatic Diseases,Department of Rheumatology, Kyung Hee University Hospital at Gangdong
[8] Kyung Hee University,Division of Rheumatology, Department of Internal Medicine
[9] Samsung Bioepis,undefined
[10] Daegu Catholic University School of Medicine,undefined
来源：
Rheumatology and Therapy | 2023年 / 10卷
关键词：
SB4; Etanercept; Biosimilar; Post-marketing surveillance; Real-world evidence; Safety; Effectiveness; Ankylosing spondylitis; Rheumatoid arthritis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：329 / 341
页数：12
相关论文
共 50 条
  • [1] Safety and Effectiveness of Etanercept Biosimilar SB4 for Rheumatic Diseases in South Korea: Real-World Post-marketing Surveillance Data
    Yoo, Wan-Hee
    Kang, Young Mo
    Kim, Dong Wook
    Kang, Eun Ha
    Lee, Yeon-Ah
    Suh, Chang-Hee
    Sung, Yoon-Kyoung
    Lee, Sang-Hoon
    Gu, Dong-Ha
    Lee, Jiwon
    Choe, Jung-Yoon
    [J]. RHEUMATOLOGY AND THERAPY, 2023, 10 (02) : 329 - 341
  • [2] Real-World Safety and Effectiveness of Golimumab in Rheumatic Diseases: Post-Marketing Surveillance in Korea
    Kim, Hyeongyeong
    Kim, Youngdoe
    Lee, YoungJa
    [J]. RHEUMATOLOGY AND THERAPY, 2021, 8 (03) : 1393 - 1404
  • [3] Real-World Safety and Effectiveness of Golimumab in Rheumatic Diseases: Post-Marketing Surveillance in Korea
    Hyeongyeong Kim
    Youngdoe Kim
    YoungJa Lee
    [J]. Rheumatology and Therapy, 2021, 8 : 1393 - 1404
  • [4] Real-world safety and effectiveness of CT-P6 (biosimilar trastuzumab): A post-marketing surveillance study in Korea
    Park, Min-Ho
    Kim, Tea Hyun
    Seo, Jae Hong
    Park, Jung Ho
    Seong, Min-Ki
    Park, Keon Uk
    Kim, Min Kyoon
    Chang, Myungchul
    Koh, Su-Jin
    Lee, Moon Hee
    Lim, Seung Taek
    Yoo, Young Bum
    Oh, So Yeon
    Kim, Sung Hyun
    Park, Tae Hong
    Ju, Hana
    Baek, Eric Hyungseok
    Kim, Sinhye
    Kim, Nahyun
    Lee, Eunkyung
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [5] Real-World Evidence on Etanercept Biosimilar SB4 in Etanercept-Naive or Switching Patients: A Systematic Review
    Ebbers, Hans C.
    Pieper, Burkhard
    Issa, Amine
    Addison, Janet
    Freudensprung, Ulrich
    Rezk, Mourad F.
    [J]. RHEUMATOLOGY AND THERAPY, 2019, 6 (03) : 317 - 338
  • [6] Safety and Effectiveness of SB2 (Infliximab Biosimilar) in Adult Patients with Immune-Mediated Inflammatory Diseases: A Post-Marketing Surveillance in Korea
    Kim, Dong W.
    Lee, Yousun
    Kim, Geuntae
    Kim, Sang H.
    Cho, Dae H.
    Choi, Jeongmin
    Kwon, Yong H.
    Park, Younjin
    Choi, Wooree
    Park, Dong I.
    [J]. ADVANCES IN THERAPY, 2023, 40 (03) : 1047 - 1061
  • [7] Safety and Effectiveness of SB2 (Infliximab Biosimilar) in Adult Patients with Immune-Mediated Inflammatory Diseases: A Post-Marketing Surveillance in Korea
    Dong W. Kim
    Yousun Lee
    Geuntae Kim
    Sang H. Kim
    Dae H. Cho
    Jeongmin Choi
    Yong H. Kwon
    Younjin Park
    Wooree Choi
    Dong I. Park
    [J]. Advances in Therapy, 2023, 40 : 1047 - 1061
  • [8] Efficacy and safety of original and biosimilar etanercept (SB4) in active rheumatoid arthritis - A comparison in a real-world national cohort
    Codreanu, Catalin
    Popescu, Claudiu C.
    Mogosan, Corina
    Enache, Luminita
    Daia, Sanziana
    Ionescu, Ruxandra
    Opris-Belinski, Daniela
    [J]. BIOLOGICALS, 2019, 62 : 27 - 32
  • [9] Real-world safety and effectiveness of lenvatinib in unresectable hepatocellular carcinoma in Korea: post-marketing study
    Kang, Wonseok
    Kim, Yoon Jun
    Kim, Seung Up
    Seo, Yeon Seok
    Kim, Jin-Wook
    Kim, Ji Hoon
    Park, Soo Young
    Baek, Yang-Hyun
    Kim, Kang Mo
    Lee, Hae Lim
    Yoon, Ki Tae
    Kim, Hyeyeong
    Cheong, Jae Youn
    Hwang, Jae Seok
    Kim, Ju Hyun
    Kim, Kwang Min
    Sung, Pil Soo
    Kim, Jieun
    Kim, Do Young
    [J]. FUTURE ONCOLOGY, 2024,
  • [10] The real-world use of istradefylline for Parkinsons disease: Post-marketing surveillance of safety and effectiveness in Japan
    Takahashi, Makio
    Itou, Satoru
    Horiguchi, Shuji
    Tsuji, Yukie
    [J]. NEUROLOGY, 2022, 98 (18)
12345